Cargando…
Theophylline in Treatment of COVID-19 Induced Sinus Bradycardia
This is a retrospective case series of two patients with laboratory-confirmed coronavirus 2 (SARS-CoV-2) infection, presented to the University of Arkansas for Medical Sciences in January 2021. Medical records of these patients were reviewed using the EPIC electronic health record system. Clinical,...
Autores principales: | Sawalha, Khalid, Habash, Fuad J., Vallurupalli, Srikanth, Paydak, Hakan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293092/ https://www.ncbi.nlm.nih.gov/pubmed/34205865 http://dx.doi.org/10.3390/clinpract11020047 |
Ejemplares similares
-
Inappropriate Sinus Tachycardia Following Viral Illness
por: Sawalha, Khalid, et al.
Publicado: (2021) -
Utilizing the Cool-Down Phenomenon to Differentiate Supraventricular Tachycardias in a Patient with COVID-19 Infection
por: Sawalha, Khalid, et al.
Publicado: (2021) -
A comparison of anti‐arrhythmic efficacy of carvedilol vs metoprolol succinate in patients with implantable cardioverter‐defibrillators
por: Ayan, Mohamed, et al.
Publicado: (2019) -
ST Segment Elevation and Depressions in Supraventricular Tachycardia without Coronary Artery Disease
por: Habash, Fuad, et al.
Publicado: (2018) -
REMDESIVIR-INDUCED EXTREME SINUS BRADYCARDIA IN COVID-19
por: Hamilton, Steven A., et al.
Publicado: (2022)